Online inquiry

IVTScrip™ mRNA-Human ARL14EP, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK25936MR)

This product GTTS-WK25936MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & 5-Methoxy-UTP. It ecodes the ARL14EP protein. This product can be used in Natural killer T (NKT) cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methoxy-UTP
5' Cap Cap 1
Species Human
RefSeq NM_152316.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 120534
UniProt ID Q8N8R7
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARL14EP, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) (GTTS-WK25936MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK18830MR IVTScrip™ mRNA-Human ANKRD50, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ANKRD50
GTTS-WK17321MR IVTScrip™ mRNA-Human ANKRD36BP1, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA ANKRD36BP1
GTTS-WK28607MR IVTScrip™ mRNA-Human ARHGEF10, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARHGEF10
GTTS-WK28350MR IVTScrip™ mRNA-Human ARL6IP6, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ARL6IP6
GTTS-WK23814MR IVTScrip™ mRNA-Human ARHGEF26, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ARHGEF26
GTTS-WK19722MR IVTScrip™ mRNA-Human ANKRD36BP2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ANKRD36BP2
GTTS-WK22370MR IVTScrip™ mRNA-Human ARPC4-TTLL3, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ARPC4-TTLL3
GTTS-WK21800MR IVTScrip™ mRNA-Human ASB8, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ASB8
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10AM EDT | May 19, 2026

Register Now →